Drug profile · INN
lofexidine hydrochloride
LOFEXIDINE HYDROCHLORIDE
lofexidine hydrochloride (LOFEXIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — lofexidine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
lofexidine hydrochloride (LOFEXIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lofexidine hydrochloride?
lofexidine hydrochloride (LOFEXIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lofexidine hydrochloride?
LOFEXIDINE HYDROCHLORIDE is a marketed brand name for lofexidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lofexidine hydrochloride?
lofexidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.